CERAGENIX PHARMACEUTICALS, INC. 4

4 · CERAGENIX PHARMACEUTICALS, INC. · Filed Jun 8, 2007

Insider Transaction Report

Form 4
Period: 2007-06-06
Sperber Jeffrey S
DirectorChief Financial Officer
Transactions
  • Award

    Stock options

    2007-06-06$1.83/sh+135,000$247,050135,000 total
    Exercise: $1.83From: 2008-06-06Exp: 2017-06-06Common stock (135,000 underlying)
Holdings
  • Stock options

    Exercise: $1.00From: 2005-01-15Exp: 2015-01-15Common stock (400,000 underlying)
    400,000
  • Stock options

    Exercise: $2.25From: 2007-06-30Exp: 2016-06-30Common stock (85,300 underlying)
    85,300
Footnotes (1)
  • [F1]Issued pursuant to annual grant

Documents

1 file
  • 4
    a4.xmlPrimary

    4